Literature DB >> 11394653

Eotaxin expression and eosinophil infiltrate in the liver of patients with drug-induced liver disease.

B N Pham1, J Bemuau, F Durand, A Sauvanet, C Degott, L Prin, A Janin.   

Abstract

BACKGROUND: Drug-induced liver disease is due to intrinsic or idiosyncratic hepatotoxins. Liver parenchyma is then infiltrated by immunocompetent cells. Eosinophils are primarily tissue leukocytes which are attracted into tissues by various chemoattractants, including chemokines. The aim of this study was to study eosinophils in the livers of patients with drug-induced liver disease.
METHODS: Immunohistochemical studies with antibodies against eosinophil cationic proteins (major basic protein, eosinophil-derived neurotoxin and eosinophil cationic protein), cytokines (interleukin 5 (IL-5), interleukin 3 (IL-3) and granulocyte-macrophage colony stimulating factor (GM-CSF)) and chemokines (eotaxin and RANTES (Regulated upon Activation Normal T cell Expressed and Secreted)) were performed to assess the in situ activation of the liver-infiltrating eosinophils of 14 patients with drug-induced liver disease and 19 controls.
RESULTS: Eosinophils were only observed in patients with drug-induced liver disease. Eosinophils were morphologically normal when hepatitis was due to paracetamol whereas eosinophils had granular changes when hepatitis was due to an idiosyncratic hepatotoxin. Eotaxin was detected in all patients with drug-induced liver disease, whereas RANTES was detected in three of them. IL-5, IL-3 or GM-CSF were not detected.
CONCLUSIONS: In patients with drug-induced liver disease, the recruitment of eosinophils in the liver may depend on eotaxin expression. Eosinophil changes may vary according to the type of drug.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11394653     DOI: 10.1016/s0168-8278(00)00057-x

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  10 in total

1.  Eosinophils mediate the pathogenesis of halothane-induced liver injury in mice.

Authors:  William R Proctor; Mala Chakraborty; Lynette S Chea; Jeffrey C Morrison; Julia D Berkson; Kenrick Semple; Mohammed Bourdi; Lance R Pohl
Journal:  Hepatology       Date:  2013-03-15       Impact factor: 17.425

2.  Trans-activation of eotaxin-1 by Brg1 contributes to liver regeneration.

Authors:  Zhiwen Fan; Ming Kong; Wenhui Dong; Chunlong Dong; Xiulian Miao; Yan Guo; Xingyu Liu; Shuying Miao; Lin Li; Tingting Chen; Yeqing Qu; Fei Yu; Yunfei Duan; Yunjie Lu; Xiaoping Zou
Journal:  Cell Death Dis       Date:  2022-05-25       Impact factor: 9.685

3.  IP-10 protects while MIP-2 promotes experimental anesthetic hapten - induced hepatitis.

Authors:  Dolores B Njoku; Zhaoxia Li; Jenelle L Mellerson; Rajni Sharma; Monica V Talor; Nicole Barat; Noel R Rose
Journal:  J Autoimmun       Date:  2009-01-07       Impact factor: 7.094

4.  Thymic stromal lymphopoietin and interleukin-4 mediate the pathogenesis of halothane-induced liver injury in mice.

Authors:  William R Proctor; Mala Chakraborty; Aaron M Fullerton; Midhun C Korrapati; Pauline M Ryan; Kenrick Semple; Jeffrey C Morrison; Julia D Berkson; Lynette S Chea; Qian Yang; Albert P Li; Rosanne Spolski; Erin E West; Yrina Rochman; Warren J Leonard; Mohammed Bourdi; Lance R Pohl
Journal:  Hepatology       Date:  2014-05-20       Impact factor: 17.425

5.  Liraglutide-induced autoimmune hepatitis.

Authors:  Emily Kern; Lisa B VanWagner; Guang-Yu Yang; Mary E Rinella
Journal:  JAMA Intern Med       Date:  2014-06       Impact factor: 21.873

6.  Differential serum levels of eosinophilic eotaxins in primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis.

Authors:  Abdolamir Landi; Tobias J Weismuller; Tim O Lankisch; Deanna M Santer; D Lorne J Tyrrell; Michael P Manns; Michael Houghton
Journal:  J Interferon Cytokine Res       Date:  2013-10-29       Impact factor: 2.607

7.  HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection.

Authors:  François M J Lamoury; Behzad Hajarizadeh; Elizabeth Keoshkerian; Jordan J Feld; Janaki Amin; Suzy Teutsch; Gail V Matthews; Margaret Hellard; Gregory J Dore; Andrew R Lloyd; Tanya L Applegate; Jason Grebely
Journal:  BMC Infect Dis       Date:  2016-06-01       Impact factor: 3.090

Review 8.  The Dual Role of Innate Immune Response in Acetaminophen-Induced Liver Injury.

Authors:  Tao Yang; Han Wang; Xiao Wang; Jun Li; Longfeng Jiang
Journal:  Biology (Basel)       Date:  2022-07-14

Review 9.  Differential Location and Distribution of Hepatic Immune Cells.

Authors:  Maria Alice Freitas-Lopes; Kassiana Mafra; Bruna A David; Raquel Carvalho-Gontijo; Gustavo B Menezes
Journal:  Cells       Date:  2017-12-07       Impact factor: 6.600

10.  Orally administered anti-eotaxin-1 monoclonal antibody is biologically active in the gut and alleviates immune-mediated hepatitis: A novel anti-inflammatory personalized therapeutic approach.

Authors:  Tawfik Khoury; Dory Rotnemer-Golinkin; Lidya Zolotarev; Yaron Ilan
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.